共查询到20条相似文献,搜索用时 15 毫秒
1.
August A Mueller C Weaver V Polanco TA Walsh ER Cantorna MT 《The Journal of nutrition》2006,136(3):695-699
The peroxisome proliferator-activated receptors (PPARs) belong to the larger superfamily of steroid/thyroid nuclear receptors. PPARgamma is expressed in a number of hematopoietic cells, including dendritic cells, eosinophils, macrophages, and T cells. A number of lipids and synthetic compounds interact with PPARgamma, that, depending on the cell type, results in the regulation of specific genes. There is now a large body of data indicating that allergic asthma is the result of a predominant type-2 helper T cell immune response including IL-4, -5 and -13, eosinophilic inflammation in the lungs, mucous production, and airway hyperresponsiveness (AHR). Targeting the production of these type-2 helper T cell mediated cytokines has been proposed as a way to regulate this disease. Because PPARgamma ligands can affect T cell cytokine production in vitro, we have examined whether these ligands affect symptoms of allergic asthma in a murine model of this disease. We discuss data showing that ciglitazone and GW1929, two agonistic ligands for PPARgamma, significantly inhibited airway inflammation during allergic asthma induction. Oral treatment with ciglitazone and GW1929 inhibited airway inflammation, with less of an effect on AHR. By contrast, intranasal exposure to GW1929 significantly reduced AHR following exposure to allergen, while GW9662, a PPARgamma antagonist, had no effect. In vitro, T cells from ciglitazone-treated mice secreted significantly less IL-4 and IFN-gamma in response to restimulation. These data suggest that PPARgamma agonists may be useful for the treatment of allergic asthma. 相似文献
2.
目的:观察槐杞黄颗粒对哮喘模型肺组织转化生长因子-β(transforming growth factor-β,TGF-β)表达的干预作用。方法:将60只BALB/c哮喘模型鼠随机分为空白对照组、哮喘模型组及槐杞黄颗粒干预组(每组20只);除空白对照组外其他各组小鼠在试验第1天、第7天和第14天通过腹腔注射0.2 ml混有40 mg氢氧化铝和10μg OVA的pH7.4的PBS液致敏,在试验第15天用5%的OVA对小鼠进行雾化激发,连续一周;槐杞黄颗粒干预组在致敏阶段即每日加用槐杞黄颗粒胃内注入5 g/d,时间为1个月;所有小鼠在实验1个月后杀死,分别用ELISA以及免疫组化方法检测血中IgE、IL-4水平以及肺组织TGF-β的表达。结果:槐杞黄颗粒干预组1个月后血中IgE、IL-4水平及肺组织TGF-β的表达明显低于哮喘模型组,血中的IFN-γ水平较哮喘模型组明显增多,差异均有统计学意义(P<0.05)。结论:槐杞黄颗粒长期使用可能会逆转过敏性炎症,并且对哮喘模型肺组织TGF-β的表达有明显的抑制作用。 相似文献
3.
目的观察磷酸酰肌醇-3激酶(PI3K)抑制剂LY294002对卵白蛋白(OVA)诱导哮喘小鼠气道炎症的影响。方法Balb/c小鼠30只,随机分为三组,每组10只:PI3K抑制剂治疗组(LY组),OVA组和正常对照组(NC组)。通过OVA多次腹腔注射致敏和反复雾化激发,建立哮喘小鼠模型。末次抗原激发后48h收集支气管肺泡灌洗液(BALF)和骨髓标本,计数细胞总数和嗜酸性粒细胞(Eos),并行肺组织学检查。结果与OVA组比较,LY组BALF中细胞总数及Eos绝对数明显减少(p<0.05);肺组织中细支气管、血管周围Eos浸润得到控制,气道粘液分泌减少。结论PI3K抑制剂(LY294002)对卵白蛋白(OVA)致敏的哮喘小鼠气道炎症具有抑制作用。 相似文献
4.
Terumi Midoro-Horiuti Ruby Tiwari Cheryl S. Watson Randall M. Goldblum 《Environmental health perspectives》2010,118(2):273-277
Background
We recently reported that various environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators in vitro.Objectives
We hypothesized that environmental estrogens would enhance allergic sensitization as well as bronchial inflammation and responsiveness. To test this hypothesis, we exposed fetal and neonatal mice to the common environmental estrogen bisphenol A (BPA) via maternal loading and assessed the pups’ response to allergic sensitization and bronchial challenge.Methods
Female BALB/c mice received 10 μg/mL BPA in their drinking water from 1 week before impregnation to the end of the study. Neonatal mice were given a single 5 μg intraperitoneal dose of ovalbumin (OVA) with aluminum hydroxide on postnatal day 4 and 3% OVA by nebulization for 10 min on days 13, 14, and 15. Forty-eight hours after the last nebulization, we assessed serum IgE antibodies to OVA by enzyme-linked immunosorbent assay (ELISA) and airway inflammation and hyperresponsiveness by enumerating eosinophils in bronchoalveolar lavage fluid, whole-body barometric plethysmography, and a forced oscillation technique.Results
Neonates from BPA-exposed mothers responded to this “suboptimal” sensitization with higher serum IgE anti-OVA concentrations compared with those from unexposed mothers (p < 0.05), and eosinophilic inflammation in their airways was significantly greater. Airway responsiveness of the OVA-sensitized neonates from BPA-treated mothers was enhanced compared with those from unexposed mothers (p < 0.05).Conclusions
Perinatal exposure to BPA enhances allergic sensitization and bronchial inflammation and responsiveness in a susceptible animal model of asthma. 相似文献5.
In utero exposure to environmental tobacco smoke potentiates adult responses to allergen in BALB/c mice 总被引:1,自引:1,他引:0
Penn AL Rouse RL Horohov DW Kearney MT Paulsen DB Lomax L 《Environmental health perspectives》2007,115(4):548-555
BACKGROUND: Fetal stress has been linked to adult atherosclerosis, obesity, and diabetes. Epidemiology studies have associated fetal exposure to maternal smoking and postnatal exposure to environmental tobacco smoke (ETS) with increased asthma risk. OBJECTIVE: We tested the hypothesis, in a mouse model of asthma, that in utero ETS exposure alters airway function and respiratory immune responses in adults. METHODS: Pregnant Balb/c mice were exposed daily to ETS or HEPA-filtered air (AIR). Offspring inhaled aerosolized ovalbumin (OVA) or saline in weeks 7-8. Regardless of whether they inhaled OVA or saline, mice were sensitized by OVA injections in weeks 11 and 13 followed by OVA aerosol challenge in weeks 14-15. At three time points, we assessed OVA-specific serum immunoglobins, bronchoalveolar lavage cells and cytokines, lung and nasal histopathology, and airway hyperresponsiveness (AHR). RESULTS: At 6 weeks, we found no significant differences between in utero ETS and AIR mice. At 10 weeks, following OVA aerosol, ETS mice displayed greater AHR than AIR mice (alpha = 0.05), unaccompanied by changes in histopathology, cytokine profile, or antibody levels. At 15 weeks, mice that had inhaled saline in weeks 7-8 developed airway inflammation: eosinophilia (alpha = 0.05), interleukin-5 (alpha = 0.05), and AHR (alpha = 0.05) were greater in ETS mice than in AIR mice. Mice that had inhaled OVA in weeks 7-8 demonstrated no airway inflammation after sensitization and challenge. CONCLUSION: In utero ETS exposure exacerbates subsequent adult responses to initial allergen exposure. 相似文献
6.
7.
KL Ritzenthaler AM Shahin TD Shultz N Dasgupta MA McGuire MK McGuire 《The Journal of nutrition》2012,142(9):1645-1651
The c9,t11-18:2 isomer of conjugated linoleic acid (c9,t11-CLA) represents the main dietary CLA form with putative health benefits. Whereas CLA intake influences the tissue CLA concentration, little is known about the association between dietary CLA and the CLA content of plasma lipid fractions. This study was designed to document fasting and nonfasting plasma c9,t11-CLA concentrations in a population of free-living adults (n = 94) and relate these concentrations to c9,t11-CLA intake. We also determined the c9,t11-CLA content of the primary plasma lipid fractions in a subset (n = 50) of our participants, related these to c9,t11-CLA intake, and determined whether c9,t11-CLA intake or plasma c9,t11-CLA was correlated with plasma cholesterol. Mean fasting plasma c9,t11-CLA concentrations were 0.46 ± 0.01 and 0.54 ± 0.01% (wt:wt) of total fatty acids for men and women, respectively (P < 0.05); nonfasting concentrations were 0.28 ± 0.01 and 0.38 ± 0.01% of total fatty acids, respectively (P < 0.001). All major esterified plasma lipid fractions contained c9,t11-CLA; TG had the highest percentages. In men, c9,t11-CLA intake correlated (r = 0.47; P < 0.05) with TG c9,t11-CLA content, suggesting that TG c9,t11-CLA may serve as a biomarker for c9,t11-CLA intake. In females, there were no correlations between c9,t11-CLA intake and the c9,t11-CLA content of any esterified plasma lipid fraction. In neither sex was there a relation between dietary c9,t11-CLA or plasma c9,t11-CLA concentration and circulating lipoprotein cholesterol concentration. The influence of sex on circulating c9,t11-CLA content and further validation of biomarkers of c9,t11-CLA intake warrant further investigation. 相似文献
8.
Letona AZ Niot I Laugerette F Athias A Monnot MC Portillo MP Besnard P Poirier H 《The Journal of nutrition》2011,141(8):1437-1444
Mice fed a mixture of CLA containing t10,c12-CLA lose fat mass and develop hyperinsulinemia and hepatic steatosis due to an accumulation of TG and cholesterol. Because cholesterol is the precursor in bile acid (BA) synthesis, we investigated whether t10,c12-CLA alters BA metabolism. In Expt. 1, female C57Bl/6J mice were fed a standard diet for 28 d supplemented with a CLA mixture (1 g/100 g) or not (controls). In Expt. 2, the feeding period was reduced to 4, 6, and 10 d. In Expt. 3, mice were fed a diet supplemented with linoleic acid, c9,t11-CLA, or t10,c12-CLA (0.4 g/100 g) for 28 d. In Expt. 1, the BA pool size was greater in CLA-fed mice than in controls and the entero-hepatic circulation of BA was altered due to greater BA synthesis and ileal reclamation. This resulted from higher hepatic cholesterol 7α-hydroxylase (CYP7A1) and ileal apical sodium BA transporter expressions in CLA-fed mice. Furthermore, hepatic Na(+)/taurocholate co-transporting polypeptide (NTCP) (-52%) and bile salt export pump (BSEP) (-77%) protein levels were lower in CLA-fed mice than in controls, leading to a greater accumulation of BA in the plasma (+500%); also, the cholesterol saturation index and the concentration of hydrophobic BA in the bile were greater in CLA-fed mice, changes associated with the presence of cholesterol crystals. Expt. 2 suggests that CLA-mediated changes were caused by hyperinsulinemia, which occurred after 6 d of the CLA diet before NTCP and BSEP mRNA downregulation (10 d). Expt. 3 demonstrated that only t10,c12-CLA altered NTCP and BSEP mRNA levels. In conclusion, t10,c12-CLA alters BA homeostasis and increases the risk of cholelithiasis in mice. 相似文献
9.
Conjugated linoleic acid isomers and cancer 总被引:2,自引:0,他引:2
We reviewed the literature regarding the effects of conjugated linoleic acid (CLA) preparations enriched in specific isomers, cis9, trans11-CLA (c9, t11-CLA) or trans10, cis12-CLA (t10, c12-CLA), on tumorigenesis in vivo and growth of tumor cell lines in vitro. We also examined the potential mechanisms by which CLA isomers may alter the incidence of cancer. We found no published reports that examined the effects of purified CLA isomers on human cancer in vivo. Incidence of rat mammary tumors induced by methylnitrosourea was decreased by c9, t11-CLA in all studies and by t10, c12-CLA in just a few that included it. Those 2 isomers decreased the incidence of forestomach tumors induced by benzo (a) pyrene in mice. Both isomers reduced breast and forestomach tumorigenesis. The c9, t11-CLA isomer did not affect the development of spontaneous tumors of the intestine or mammary gland, whereas t10, c12-CLA increased development of genetically induced mammary and intestinal tumors. In vitro, t10, c12-CLA inhibited the growth of mammary, colon, colorectal, gastric, prostate, and hepatoma cell lines. These 2 CLA isomers may regulate tumor growth through different mechanisms, because they have markedly different effects on lipid metabolism and regulation of oncogenes. In addition, c9, t11-CLA inhibited the cyclooxygenase-2 pathway and t10, c12-CLA inhibited the lipooxygenase pathway. The t10, c12-CLA isomer induced the expression of apoptotic genes, whereas c9, t11-CLA did not increase apoptosis in most of the studies that assessed it. Several minor isomers including t9, t11-CLA; c11, t13-CLA; c9, c11-CLA; and t7, c11-CLA were more effective than c9, t11-CLA or t10, c12-CLA in inhibiting cell growth in vitro. Additional studies with purified isomers are needed to establish the health benefit and risk ratios of each isomer in humans. 相似文献
10.
Antiproliferative effects of conjugated linoleic acid on human colon adenocarcinoma cell line Caco-2
Conjugated linoleic acid (CLA) reduces body fat reserves, and reduces atherogenesis and type II diabetes in animal experiments. It has been reported that CLA have isomeric-specificity, such as c9, t11 CLA with anticancer activity. The antiproliferative effects of two isomers of CLA (c9, t11-CLA, t9, t11-CLA) and their mixture on the human colon adenocarcinoma cell line Caco-2 were investigated in this paper. Caco-2 were incubated in serum-free medium. The antiproliferative effects of different concentrations (0, 25, 50, 100, 200 micromol/L) of linoleic acid (LA), c9, t11-CLA, t9, t11-CLA (the purity of LA and CLA was 96%) and a mixture of c9, t11-CLA and t9, t11- CLA (1:1 v/v) on caco-2 in various action time (1d, 2d, 3d, 4d) were tested in the present study. The antiproliferative effects of four substances in the same concentration and with the same action time were compared. All substances tested could inhibit Caco-2 cell proliferation. The higher anti-proliferation activity in the four materials is the mixture of CLA, then is t9,t11-CLA, c9,t11-CLA, and linoleic acid respectively. The activity is closely related to treatment time and concentration. The isomer t9, t11-CLA itself was found to have antiproliferative activity. 相似文献
11.
目的 探讨γ-维生素E(γ-T)对哮喘的治疗作用及机制。方法 将40只雄性Balb/c小鼠(4周,18~20 g)随机分为正常组、哮喘组、地塞米松组及γ-T治疗组。给予小鼠腹腔注射及雾化吸入卵白蛋白建立哮喘气道炎症反应模型,分别给予地塞米松及γ-T,正常组仅给予生理盐水。28 d后处死小鼠,留取血清及肺泡灌洗液。ELISA法测定各组血清及肺泡灌洗液中嗜酸性粒细胞趋化因子(eotaxin)的含量。用one-way ANOVA检验组间差异,P<0.05具有统计学意义。结果 哮喘组小鼠血清及肺泡灌洗液中eotaxin浓度均较正常组升高,地塞米松组及γ-T组均较哮喘组下降。在血清中地塞米松组下降最明显,γ-T组次之,γ-T组与哮喘组,γ-T组与地塞米松组相比差异无统计学意义(P>0.05);在BALF中,γ-T组的eotaxin下降最明显,与哮喘组相比,二者间差异明显(P<0.05);γ-T组与地塞米松组相比,二者差异无统计学意义(P>0.05)。 结论 γ-T有利于减少哮喘小鼠肺组织eotaxin,γ-T可能是有用的抗哮喘药物。 相似文献
12.
内毒素在小鼠过敏性哮喘模型所起作用的实验研究 总被引:1,自引:0,他引:1
目的建立小鼠过敏性哮喘模型,在过敏原的致敏和激发阶段给予不同剂量内毒素(即脂多糖LPS),探讨内毒素在哮喘模型中的作用机制。方法建立BALB/c小鼠哮喘模型,设立实验组和对照组开展后续实验。实验组包括:鸡卵清白蛋白(OVA)致敏,OVA激发组;OVA致敏,LPS激发组;OVA致敏,OVA+LPS联合激发组;LPS暴露于OVA致敏前,OVA激发组;对照组包括试剂对照组和健康对照组。各实验组的LPS剂量均分为高、中、低三个剂量组。通过测定小鼠气道阻力和肺顺应性来反映其肺功能改变;流式细胞术(FCM)测定FITC、PE阳性细胞数,表征CD4+CD2+5调节性T淋巴细胞(以下简称Treg细胞)的相对比例;荧光实时聚合酶链反应定量测定肺脏和脾脏Foxp3mRNA表达的水平;ELISA法测定血浆总IgE和OVA特异性IgE水平,抗体夹心ELISA法测定支气管肺泡灌洗液(BALF)中Th2细胞因子(IL-4和IL-5)的水平;计数BALF中白细胞总数和嗜酸性粒细胞等各类白细胞所占百分比;常规病理切片观察肺组织改变情况。结果结果表明,与哮喘模型组小鼠相比,在LPS各处理组中,总体上能诱导Treg细胞的产生,改善肺功能,降低IgE滴度,降低Th2介导的免疫反应,同时诱导肺部炎症。尤其是在致敏阶段腹腔注射内毒素可以缓解由过敏原诱导的气道炎症和改善肺功能,诱导肺组织和脾组织Foxp3mRNA表达的增加。结论LPS抑制了Th2介导的过敏反应,可能与Foxp3表达量的增加相关,后者诱导Treg细胞增殖,对哮喘症状起到缓解作用。 相似文献
13.
14.
Yu Deng Wei Li Yan Luo Li J. Wang Xiao H. Xie Jian Luo Zheng X. Luo Xiao D. Zhao Zhou Fu En M. Liu 《Vaccine》2014
Objective
The Mycobacterium bovis Bacillus Calmette-Guerin (BCG) neonatal vaccination inhibits allergy-induced pathologic changes. However, the mechanisms underlying this process are unclear. This study aimed to investigate the role of interferon (IFN)-γ and interleukin (IL)-17 in the protective effects of the BCG neonatal vaccination on allergic pulmonary inflammation and airway hyperresponsiveness (AHR).Methods
Wild type (WT)-neonate and IL-17 knock out (KO) neonate mice were vaccinated with BCG. A murine asthma model was developed by sensitization and then challenging with ovalbumin (OVA). Recombinant IL-17 or recombinant IFN-γ was delivered to the airway to overexpress IL-17 or IFN-γ. An anti-IFN-γ neutralizing antibody was used to block the effects of IFN-γ.Results
We found exogenous IL-17 delivered to the airway reversed the anti-asthma effects of the neonatal BCG vaccination. BCG neonatal vaccination further reduced OVA-induced inflammation and AHR in IL-17 KO mice. Inhibition of IFN-γ in BCG neonatal vaccinated OVA-induced asthma model mice led to a further reduction in airway inflammation and AHR. In addition, airway inflammation and AHR were robust following treatment with exogenous IFN-γ. Neutralizing IL-17 was not sufficient to block OVA-induced airway inflammation and AHR. In IL-17 KO mice, airway inflammation and AHR did not occur following treatment with an anti-IFN-γ neutralizing antibody.Conclusions
In an OVA-induced murine asthma model, inhibition of IFN-γ enhanced the anti-asthma effects of BCG neonatal vaccination. 相似文献15.
目的 研究布地奈德(BUD)对慢性哮喘小鼠支气管上皮细胞的血清类黏蛋白1样蛋白3(ORMDL3),基质金属蛋白酶-9(MMP-9)表达的影响,及其对气道重塑的干预作用。方法 应用BALB/C小鼠随机分为对照组、哮喘组、BUD组,用OVA(卵清蛋白)和氢氧化铝建立哮喘小鼠模型,为进一步了解布地奈德对气道重塑的干预机制,第21天BUD组小鼠在OVA激发前30 min吸入布地奈德。12周后,用苏木精-伊红染色(HE staining)分析气道壁厚度改变,Masson染色观察气道胶原沉积,通过免疫组织化学染色法(immunohistochemistry staining),蛋白质印迹法(western blot),实时荧光定量PCR(real-time PCR)测定小鼠支气管上皮细胞ORMDL3,MMP-9的表达含量。结果 12周后,哮喘组和BUD组的气道壁厚度增加,胶原蛋白沉积,ORMDL3,MMP-9表达明显高于对照组,BUD组气道病理改变程度和ORMDL3,MMP-9的升高幅度均不及哮喘组。经相关性分析可发现,MMP-9表达增加与ORMDL3基因的表达上调具有相关性,并且二者的表达增高与气道壁厚度有明显相关性。结论 布地奈德可能通过下调ORMDL3,MMP-9基因的表达,抑制慢性哮喘气道重塑进程。 相似文献
16.
17.
Changhua L Jindong Y Defa L Lidan Z Shiyan Q Jianjun X 《The Journal of nutrition》2005,135(2):239-244
We investigated the anti-inflammatory role of conjugated linoleic acid (CLA) in inflammation-challenged weaned pigs and in in vitro cultured peripheral blood mononuclear cells (PBMCs). To test the hypothesis that inflammation responses can be attenuated by dietary CLA supplementation, we used an acute inflammation model in which pigs were injected with lipopolysaccharide (LPS). After 14 d of dietary supplementation with either 2% soybean oil or 2% CLA, half of the pigs in each diet group were challenged with LPS. Dietary CLA alleviated growth depression and prevented the elevations in production and mRNA expression of proinflammatory cytokines [i.e., interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha] induced by the LPS challenge. CLA enhanced the expression of interleukin-10 (IL-10) and peroxisome proliferator-activated receptor-gamma (PPARgamma) in spleen and thymus. To further elucidate the inhibitory effects and the mechanism of action of CLA on cytokine profiles (i.e., IL-1beta, IL-6, and TNF-alpha), PBMCs were isolated from weaned pigs and cultured in media containing cis-9, trans-11 (9c,11t) CLA and trans-10, cis-12 (10t,12c) CLA. Each CLA isomer suppressed the production and expression of IL-1beta, IL-6, and TNF-alpha, and enhanced PPARgamma activation and gene expression in cultured PBMCs. At the molecular level, the inhibitory actions of CLA on IL-1beta, IL-6, and TNF-alpha are attributable mainly to 10t,12c-CLA and the anti-inflammatory properties of CLA are mediated, at least in part, through a PPARgamma-dependent mechanism. 相似文献
18.
目的为阐明胸腺基质淋巴生成素受体(Thymic stromal lymphopoietin receptor,TSLPR)在超敏原引起的气道炎症应答中的作用,并在小鼠模型中探讨局部封闭TSLPR用以缓解哮喘的可能性。方法对TSLPR抗体或同型抗体预处理,且以鸡卵白蛋白(OVA)诱导的各组小鼠,分别行气道浸润细胞的分类和记数、H&E和PAS的肺组织染色分析;并以酶联免疫吸附测定法(ELISA)检测支气管肺泡灌洗液中炎性细胞因子;进一步分析OVA激发的小鼠树突状细胞(DCs)的迁移能力和成熟状态。结果在小鼠OVA致敏前施以抗TSLPR抗体可显著减少气道粘液的分泌、嗜酸性粒细胞和淋巴细胞浸润;同时引发IL-4、IL-5水平的明显下降。而作为其机制之一,TSLPR的中和作用可阻止超敏原诱导的DCs的成熟和迁移。结论封闭TSLPR介导的信号通路可缓解哮喘小鼠的气道炎症反应,有望成为一项新的防治气道变应性疾病策略。 相似文献
19.
Background Atherosclerosis is characterized by extensive thickening of the arterial intima partially resulting from deposition of collagen
by vascular smooth muscle cells (SMCs). Polyunsaturated fatty acids stimulate collagen formation through NF-κB activation.
Aim of the study The present study aimed to explore the effect of conjugated linoleic acids (CLAs) which are known to inhibit NF-κB activation
on collagen formation by SMCs.
Methods Vascular SMCs were cultured with 50 μmol/l of CLA isomers (c9t11-CLA, t10c12-CLA) or linoleic acid (LA) and analysed for collagen
formation and NF-κB p50 transactivation.
Results Treatment with CLA isomers but not LA significantly reduced PDGF-stimulated [3H] proline incorporation into cell layer protein of SMCs without altering cell proliferation. Simultaneous treatment with
the PPARγ inhibitor T0070907 abrogated this effect. Treatment of SMCs with c9t11-CLA and t10c12-CLA significantly reduced
PDGF-induced NF-κB p50 activation.
Conclusions CLA isomers inhibit PDGF-stimulated collagen production by vascular SMCs, which is considered to be a hallmark of atherosclerosis,
in a PPARγ-dependent manner. Whether inhibition of the NF-κB-pathway is of significance for the reduction of collagen formation
by CLA isomers needs further investigation. 相似文献
20.
目的:研究75%c9,t11-共轭亚油酸(c9,t11-CLA)在不同条件下的氧化稳定性,并在同等条件下与亚油酸(LA)进行比较,探讨影响75%c9,t11-CLA氧化稳定性的因素。方法:测定75%c9,t11-CLA和LA在暴露于空气、充氮保护、加入0.02%没食子酸丙酯、色拉油中及0.02%Ca^2+存在条件下的过氧化值,同时进行气相色谱分析,观察5个不同时间75%c9,t11-CLA和IA含量的变化。结果:当75%c9,t11-CLA和LA在暴露于空气、充氮保护、加入0.02%没食子酸丙酯、色拉油中及0.02%Ca^2+存在的条件下,75%c9,t11-CLA在不同处理条件下的氧化稳定性顺序为:0.02%没食子酸丙酯组〉充氮保护组〉色拉油组〉暴露于空气组〉0.02%Ca^2+组(P〈0.05)。75%c9,t11-CLA的氧化速度快于亚油酸(IJA)的氧化速度(P〈0.05)。结论:0.02%没食子酸丙酯可明显提高c9,t11-CLA的氧化稳定性。增强c9,t11-CLA的稳定性已成为保护c9,t11-CLA有效生物活性的至关重要的因素。 相似文献